Treatment-Limiting Taxane-Induced Peripheral Neuropathy: Timing, Severity and Clinical Predictors in Patients Receiving Neoadjuvant TCHP.
Background Chemotherapy-induced peripheral neuropathy (CIPN) is a common and clinically significant neurotoxicity associated with taxane-based chemotherapy, which is frequently leading to treatment modification or discontinuation. In the neoadjuvant setting, treatment-limiting CIPN may compromise the delivery of planne...